165 related articles for article (PubMed ID: 32093784)
1. Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat.
Matthews D; Adegoke O; Shephard A
BMC Res Notes; 2020 Feb; 13(1):99. PubMed ID: 32093784
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of bactericidal action of amylmetacresol/2,4-dichlorobenzyl alcohol lozenges against oropharyngeal organisms implicated in pharyngitis.
Matthews D; Atkinson R; Shephard A
Int J Gen Med; 2018; 11():451-456. PubMed ID: 30568479
[TBL] [Abstract][Full Text] [Related]
3. Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection.
McNally D; Shephard A; Field E
J Pharm Pharm Sci; 2012; 15(2):281-94. PubMed ID: 22579007
[TBL] [Abstract][Full Text] [Related]
4. Virucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirus.
Shephard A; Zybeshari S
Antiviral Res; 2015 Nov; 123():158-62. PubMed ID: 26408353
[TBL] [Abstract][Full Text] [Related]
5. The effect of formulation on the antimicrobial activity of cetylpyridinium chloride in candy based lozenges.
Richards RM; Xing JZ; Weir LF
Pharm Res; 1996 Apr; 13(4):583-7. PubMed ID: 8710750
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study.
Donath F; Mallefet P; Garreffa S; Furcha R
Trials; 2018 Dec; 19(1):679. PubMed ID: 30541606
[TBL] [Abstract][Full Text] [Related]
7. Effects of cold atmospheric plasma (CAP) on bacteria and mucosa of the upper aerodigestive tract.
Becker S; Zimmermann JL; Baumeister P; Brunner TF; Shimizu T; Li YF; Morfill GE; Harréus U; Welz C
Auris Nasus Larynx; 2019 Apr; 46(2):294-301. PubMed ID: 30098846
[TBL] [Abstract][Full Text] [Related]
8. In-vitro bactericidal activity of four oral antibiotics against pathogens responsible for acute otitis media in children.
Lambert-Zechovsky N; Mariani-Kurkdjian P; Doit C; Bourgeois F; Bingen E
J Hosp Infect; 1992 Nov; 22 Suppl A():89-97. PubMed ID: 1362754
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy children.
Liassine N; Gervaix A; Hegi R; Strautman G; Suter S; Auckenthaler R
Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):217-20. PubMed ID: 10357059
[TBL] [Abstract][Full Text] [Related]
10. Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat.
Morokutti-Kurz M; Graf C; Prieschl-Grassauer E
Int J Gen Med; 2017; 10():53-60. PubMed ID: 28280379
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
12. Excipient interaction with cetylpyridinium chloride activity in tablet based lozenges.
Richards RM; Xing JZ; Mackay KM
Pharm Res; 1996 Aug; 13(8):1258-64. PubMed ID: 8865323
[TBL] [Abstract][Full Text] [Related]
13. Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial.
McNally D; Simpson M; Morris C; Shephard A; Goulder M
Int J Clin Pract; 2010 Jan; 64(2):194-207. PubMed ID: 19849767
[TBL] [Abstract][Full Text] [Related]
14. Open-label taste-testing study to evaluate the acceptability of both strawberry-flavored and orange-flavored amylmetacresol/2,4-dichlorobenzyl alcohol throat lozenges in healthy children.
Thompson A; Reader S; Field E; Shephard A
Drugs R D; 2013 Jun; 13(2):101-7. PubMed ID: 23588685
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
Yamada T; Yokota Y; Ikeda F; Mine Y; Kitada T
Chemotherapy; 1992; 38(1):28-35. PubMed ID: 1618001
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties.
Fischer J; Pschorn U; Vix JM; Peil H; Aicher B; Müller A; de Mey C
Arzneimittelforschung; 2002; 52(4):256-63. PubMed ID: 12040968
[TBL] [Abstract][Full Text] [Related]
17. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
Wallrauch-Schwarz C; Milatovic D; Braveny I
Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
19. Topical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like manner.
Buchholz V; Leuwer M; Ahrens J; Foadi N; Krampfl K; Haeseler G
Naunyn Schmiedebergs Arch Pharmacol; 2009 Aug; 380(2):161-8. PubMed ID: 19367399
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis.
Weckmann G; Hauptmann-Voß A; Baumeister SE; Klötzer C; Chenot JF
Int J Clin Pract; 2017 Oct; 71(10):. PubMed ID: 28869700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
